Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:51
Journey Medical Enterprise Value : 103.50M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 103.50M |
| November 18, 2026 | 107.45M |
| November 17, 2026 | 113.38M |
| November 16, 2026 | 107.73M |
| November 13, 2026 | 125.51M |
| November 12, 2026 | 127.21M |
| November 11, 2026 | 128.62M |
| November 10, 2026 | 128.06M |
| November 09, 2026 | 130.88M |
| November 06, 2026 | 129.47M |
| November 05, 2026 | 124.67M |
| November 04, 2026 | 136.81M |
| November 03, 2026 | 134.26M |
| November 02, 2026 | 138.50M |
| October 30, 2026 | 149.22M |
| October 29, 2026 | 156.00M |
| October 28, 2026 | 147.81M |
| October 27, 2026 | 143.30M |
| October 26, 2026 | 143.58M |
| October 23, 2026 | 144.99M |
| October 22, 2026 | 146.97M |
| October 21, 2026 | 138.78M |
| October 20, 2026 | 150.64M |
| October 19, 2026 | 149.22M |
| October 16, 2026 | 143.44M |
| Date | Value |
|---|---|
| October 15, 2026 | 147.95M |
| October 14, 2026 | 152.33M |
| October 13, 2026 | 163.62M |
| October 12, 2026 | 170.11M |
| October 09, 2026 | 181.40M |
| October 08, 2026 | 171.24M |
| October 07, 2026 | 171.24M |
| October 06, 2026 | 177.17M |
| October 05, 2026 | 192.13M |
| October 02, 2026 | 189.87M |
| October 01, 2026 | 192.97M |
| September 30, 2026 | 196.36M |
| September 29, 2026 | 179.39M |
| September 28, 2026 | 177.73M |
| September 25, 2026 | 169.71M |
| September 24, 2026 | 174.69M |
| September 23, 2026 | 179.67M |
| September 22, 2026 | 200.41M |
| September 21, 2026 | 193.22M |
| September 18, 2026 | 202.07M |
| September 17, 2026 | 203.45M |
| September 16, 2026 | 201.52M |
| September 15, 2026 | 203.45M |
| September 14, 2026 | 204.01M |
| September 11, 2026 | 199.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Talphera, Inc. | 30.73M |
| Fortress Biotech, Inc. | -36.93M |
| Relmada Therapeutics, Inc. | 129.70M |
| Turn Therapeutics, Inc. | 259.67M |
| ANI Pharmaceuticals, Inc. | 1.754B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.315M |
| Revenue (Quarterly) | 18.97M |
| Total Expenses (Quarterly) | 20.28M |
| EPS Diluted (Quarterly) | -0.0468 |
| Gross Profit Margin (Quarterly) | 63.87% |
| Profit Margin (Quarterly) | -6.93% |
| Earnings Yield | -5.63% |
| Normalized Earnings Yield | -5.630 |